GDRX GoodRx Holdings, Inc.
USHealthcareAs of 2026-07-10 16:00
Why GDRX matters now
GoodRx Holdings, Inc. (GDRX) is a US stock in Healthcare. The latest InvestLog snapshot shows $2.95 with +0.34% on the session and $1.02B in market capitalization; recent performance reads 1-month +5.56% and YTD -1.84%.
The latest financial table shown here is Q1 2026, with revenue of $194.0M, net income of $1.2M, and EPS of $0.00. Investors can compare that operating picture with valuation signals such as P/E 24.66 and FCF yield 14.3%.
The latest indexable market news headline is "GoodRx Announces Date for Second Quarter 2026 Earnings Release and Conference Call" from Business Wire.
Additional event context on this page matters because analyst consensus is Hold with a median target of $3.00; recent insider activity includes Wagner Scott filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
24.66
PEG
1.06
P/B
1.46
P/S
1.17
EV/EBITDA
7.08
DCF Value
$5.90
FCF Yield
14.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
86.6%
Operating Margin
10.7%
Net Margin
2.6%
ROE
3.3%
ROA
1.0%
ROIC
3.3%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $194.0M | $1.2M | $0.00 |
| Q4 2025 | $194.8M | $5.4M | $0.02 |
| FY 2025 | $796.9M | $30.4M | $0.09 |
| Q3 2025 | $196.0M | $1.1M | $0.00 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$3.08
Target (Median)
$3.00
Target Range
$2.75 - $3.50
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
US
Exchange
—
Beta
1.61
GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.